St. Jude Medical
COMPANY OVERVIEW
FORTUNE
St. Jude Medical is a global medical device manufacturer dedicated to transforming
the treatment of some of the world’s most expensive epidemic diseases. The company
does this by developing cost-effective medical technologies that save and improve the
lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical
employs approximately 16,000 people worldwide and has four major clinical focus
areas that include cardiac rhythm management, atrial fibrillation, cardiovascular
and neuromodulation.
COMPANY FACTS
2014 Revenue:
Global Headquarters:
Revenue (in millions)
$5.622 billion
St. Paul, Minn.
Stock Exchange: New York Stock Exchange (NYSE) / ticker STJ
500
COMPANY
FY 12
$
5,503
FY 13
$
5,501
FY 14
$
5,622
Founded: 1976 in St. Paul, Minn.
Global Reach: Operations and manufacturing facilities worldwide,
with products sold in more than 100 countries
Employees: Approximately 16,000
2014 HIGHLIGHTS
¢¢
¢¢
¢¢
¢¢
¢¢
12%
OF REVENUE
IS INVESTED IN
RESEARCH & DEVELOPMENT
Delivered on our commitment to improving patient outcomes and reducing the economic
burden of conditions such as heart failure, atrial fibrillation and chronic pain.
Net sales increased 4 percent over the prior year on a constant currency basis.
Acquired CardioMEMS, Inc., a privately held developer of the CardioMEMS™ HF System,
the first and only FDA-approved heart failure (HF) monitoring device that has been
proven to significantly reduce HF hospital admissions when used by physicians to
manage heart failure.
Acquired NeuroTherm, Inc., a privately held manufacturer and global leader in the
treatment of spinal pain using radiofrequency ablation.
Increased our quarterly dividend by 8 percent.
2014 Sales by Geography
47% U.S.
53% International
INNOVATION AT ST. JUDE MEDICAL
We believe that investing in purposeful innovation is instrumental in our success.
We are uniquely positioned for long-term growth driven by our vision to address
expensive epidemic diseases with solutions that improve lives and reduce the
economic burden on health care systems worldwide.
Atrial Fibrillation (AF): St. Jude Medical is a pioneer and a leader in the global
AF market, which is estimated at more than $2.9 billion. The company offers the
industry’s broadest product portfolio for the electrophysiology (EP) lab, aiding
physicians in the diagnosis and treatment of cardiac arrhythmias.
Cardiac Rhythm Management (CRM): We estimate that the worldwide
CRM market is approximately $10 billion in size. With the industry’s first
quadripolar pacing system featuring four pacing electrodes, St. Jude Medical
is providing physicians with innovative technology that is able to reduce
common complications seen with traditional bipolar leads when delivering
resynchronization therapy to heart failure patients.
Neuromodulation: St. Jude Medical is a strong contributor in the $2 billion
neuromodulation market. We are working to bring innovative products to
underpenetrated markets of spinal cord stimulation (SCS) and deep brain
stimulation (DBS) in order to improve patient care. During 2014, St. Jude Medical
acquired NeuroTherm, Inc., a privately held manufacturer and global leader in the
treatment of spinal pain using radiofrequency ablation.
Cardiovascular: St. Jude Medical participates in the vascular and structural
heart markets that when combined total more than $5 billion. We have strong
franchises in heart valve replacement, fractional flow reserve (FFR) and optical
coherence tomography (OCT) intravascular imaging systems, vascular closure
and left atrial appendage occlusion. In 2014, St. Jude Medical acquired
CardioMEMS, Inc., to introduce the first and only FDA-approved heart failure
monitor proven to significantly reduce heart failure hospital admissions and
improve quality of life in NYHA Class III patients.
2014 Net Sales by Product Category
24%
18%
8%
50%
18% Atrial Fibrillation
50% Cardiac Rhythm Management
8% Neuromodulation
24% Cardiovascular
Rx Only
Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.
Unless otherwise noted, ™ indicates that the name is a trademark of, or licensed to, St. Jude Medical or one of its subsidiaries. ST. JUDE MEDICAL and the nine-squares symbol are trademarks and service
marks of St. Jude Medical, Inc. and its related companies. © 2015 St. Jude Medical, Inc. All Rights Reserved.
St. Jude Medical Inc. Global Headquarters
One St. Jude Medical Drive
St. Paul, MN 55117
USA
T +1 651 756 2000| F +1 651 756 3301
Investor Contact J.C. Weigelt
T +1 651 756 4347
SJM-COR-0115-0053(1) | Item approved for global use.
SJM.com | follow us on Twitter @ StJudeMedicalIR